4.6 Letter

Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis

Journal

BRITISH JOURNAL OF HAEMATOLOGY
Volume 164, Issue 1, Pages 146-150

Publisher

WILEY-BLACKWELL
DOI: 10.1111/bjh.12564

Keywords

chronic lymphocytic leukaemia; Akt; B cell receptor; cytokine

Categories

Funding

  1. NCI NIH HHS [K23CA160345, CA95241, R01 CA095241, K23 CA160345] Funding Source: Medline

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available